Spero Therapeutics (SPRO) Current Deferred Revenue (2021 - 2025)
Spero Therapeutics' Current Deferred Revenue came in at $258,000 for Q4 2025, down 98.8% from $21.76 million a year earlier and down 89.2% from the prior quarter.
Powered by 
Analysis
Spero Therapeutics (SPRO) Current Deferred Revenue (2021 - 2025) Analysis & Trends
Going back to Q2 2021, Spero Therapeutics' Current Deferred Revenue data covers 19 quarters.
- Current Deferred Revenue carries a four-year compound annual growth rate of -38.9% (FY2021 to FY2025).
- Going back by year, Current Deferred Revenue was $21.76 million in FY2024 (-12.9%), $24.98 million in FY2023 (+301.6%), $6.22 million in FY2022 (+234.9%) and $1.86 million in FY2021.
- The Q4 2025 figure represents the lowest quarterly Current Deferred Revenue in data going back to Q2 2021.
- Year-over-year, Current Deferred Revenue has declined for five consecutive quarters, with growth averaging 13.8% over the last eight quarters.
- The fastest year-over-year change in Current Deferred Revenue over five years came in Q1 2023 (growth of 465.9%), and the weakest in Q4 2025 (a decline of 98.8%).
- Business Quant data shows SPRO's Current Deferred Revenue at $2.38 million (Q3 2025), $5.43 million (Q2 2025) and $17.23 million (Q1 2025) in the three quarters before Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn |
| 10 | Spero Therapeutics | 68.40 Mn | -127.38 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 258,000.00 |
| Sep 30, 2025 | 2.38 Mn |
| Jun 30, 2025 | 5.43 Mn |
| Mar 31, 2025 | 17.23 Mn |
| Dec 31, 2024 | 21.76 Mn |
| Sep 30, 2024 | 25.05 Mn |
| Jun 30, 2024 | 27.14 Mn |
| Mar 31, 2024 | 28.40 Mn |
| Dec 31, 2023 | 24.98 Mn |
| Sep 30, 2023 | 13.87 Mn |
| Jun 30, 2023 | 8.71 Mn |
| Mar 31, 2023 | 11.85 Mn |
| Dec 31, 2022 | 6.22 Mn |
| Sep 30, 2022 | 3.73 Mn |
| Jun 30, 2022 | 2.36 Mn |
| Mar 31, 2022 | 2.09 Mn |
| Dec 31, 2021 | 1.86 Mn |
| Sep 30, 2021 | 1.70 Mn |
| Jun 30, 2021 | 1.18 Mn |
API Access
Spero Therapeutics Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=SPRO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "SPRO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=SPRO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();